drugset / Trial / NCT00065949

Magnesium Sulfate to Prevent Brain Injury in Premature Infants

NCT00065949

RandomizedParallel-groupDouble-blindPrevention

Summary

Premature infants are at risk for acute brain injuries and long-term developmental problems such as cerebral palsy (CP). Research suggests that high levels of magnesium at and around the time of birth may decrease the risk of brain injuries. This study will evaluate the effects of giving magnesium to premature infants.

Timeline

Start
1987-08
Primary completion
Completion
2003-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Magnesium Sulfate Other / unclassified Intravenous